
    
      This study will include 152 women undergoing MAB. Women will be randomized to oxycodone 10mg
      oral versus placebo and stratified by gestational age (<7wks, 7-10wks). The primary outcome
      will be maximum reported pain score measured at 6-8 hours and 24 hours after misoprostol
      administration.
    
  